Steven E. Finkelstein, M.D., DABR, FACRO

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation oncology physician, researcher and thought leader Steven E. Finkelstein, M.D., DABR, FACRO, has joined its care team as Director of the Center of Advanced Radiation Excellence (CARE) and Director of Radiation Oncology Research.

Associated Medical Professionals of NY spans 18 locations in Central New York, including nine offices and nine hospitals. A.M.P. Radiation Oncology is the region’s leading provider of comprehensive cancer care services, providing the most advanced, effective treatments available for urological and other types of cancers. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital.

Dr. Finkelstein has treated thousands of patients with prostate cancer and genitourinary malignancies, been principal investigator for groundbreaking clinical trials, and continues contributing to prestigious scientific journals with over 11,000 literature citations with an H-Index of 42. Additionally, he is renowned in bladder, kidney and testicular cancer as well as lung, breast and skin cancers which he will also treat at A.M.P. Dr. Finkelstein is passionate about leadership in organized medicine and is a strong advocate for physicians and the patients they serve. He is a graduate of the University of Michigan, where he completed his medical degree, and spent his residency at Moffitt Cancer Center and fellowship at the National Cancer Institute, National Institutes of Health. Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “Dr. Steven Finkelstein’s extensive experience in radiation oncology care and his leadership in the medical field will be a tremendous asset to U.S. Urology Partners, Associated Medical Professionals of NY and most importantly to individuals receiving cancer care in the Central New York region. Dr. Finkelstein’s dedication will further our mission to provide the best treatment available to our patients in the most compassionate way utilizing the most advanced, proven technology for every person we are privileged to serve.”

Christopher M. Pieczonka, M.D., Chief Executive Officer of Associated Medical Professionals of NY and Corporate Director of Clinical Research of U.S. Urology Partners, stated, “The Central New York community has long been the geographic heart of New York State and is on the cusp of a significant population influx from the construction and opening of Micron Technology Inc. We have recruited Dr. Steven Finkelstein for his prowess and expertise in providing cutting-edge clinical research in all aspects of radiation oncology to our patients. Currently Associated Medical Professionals is running over 30 active clinical trials, and we anticipate exponential growth with Dr Finkelstein’s expertise.”

Steven E. Finkelstein, M.D., DABR, FACRO, stated, “I am passionate about advancing patient care for all and committed to outstanding cancer care providing access to today’s leading-edge technologies and innovative treatment options. I am excited to join the team of Associated Medical Professionals of NY and look forward to helping patients in the community.”

For more information: www.us-uro.com


Related Content

News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Breast Imaging

June 18, 2024 — Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue Breast ...

Time June 18, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Feature | Imaging Technology News - ITN

Dear Friends and Readers of ITN, Can you spare 3 minutes today to give us some feedback? Please share your insight with ...

Time June 17, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Neuro Imaging

June 12, 2024 — Brainet, a developer of cutting-edge diagnostic tools for assessing brain health, and SimonMed Imaging ...

Time June 12, 2024
arrow
News | SNMMI

June 11, 2024 — Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s ...

Time June 11, 2024
arrow
Subscribe Now